Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
SEC Accession No. 0001130319-08-000501
Filing Date
2008-06-17
Accepted
2008-06-16 18:07:32
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-10 o41074fv10za.htm F-10/A 282951
2 EXHIBIT 5.1 o41074exv5w1.htm EX-5.1 2333
3 EXHIBIT 5.2 o41074exv5w2.htm EX-5.2 3525
4 GRAPHIC o41074o4107403.gif GRAPHIC 1680
5 GRAPHIC o41074o4107402.gif GRAPHIC 2022
6 GRAPHIC o41074o4107401.gif GRAPHIC 8396
7 GRAPHIC o41074o4107405.gif GRAPHIC 12079
8 GRAPHIC o41074o4107406.gif GRAPHIC 3457
9 GRAPHIC o41074o4107404.gif GRAPHIC 4125
  Complete submission text file 0001130319-08-000501.txt   334864
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10/A | Act: 33 | File No.: 333-151513 | Film No.: 08901500
SIC: 2834 Pharmaceutical Preparations